School of Medicine


Showing 1-6 of 6 Results

  • Anusha Kalbasi, MD

    Anusha Kalbasi, MD

    Associate Professor of Radiation Oncology (Radiation Therapy)

    BioDr. Kalbasi is radiation oncologist and physician-scientist at the Stanford Cancer Institute, specializing in the treatment of patients with solid malignancies, especially sarcoma and melanoma. He actively leads early phase clinical trials related to immunotherapy and/or radiation therapy.

    Dr. Kalbasi's laboratory studies cancer immunology, with a focus on manipulating the cell-intrinsic signals of immune cells and cancer cells to influence the outcomes of immunotherapy and/or radiation. The lab integrates a variety of approaches including cell and protein engineering, synthetic biology, cell signaling, genomics, and analysis of samples from patients on clinical trials. The lab is actively engaged in projects involving engineering T cell therapies (TCR, CAR, TIL), T cell engagers, cytokine therapies, innate immune agonists and radiation therapy.

    Dr. Kalbasi was previously assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA and chief of sarcoma radiotherapy at the UCLA Jonsson Comprehensive Cancer Center, where he was named a NextGen Star by the American Association of Cancer Research. Dr. Kalbasi’s work has been published in leading journals including Nature, Science Translational Medicine, JAMA Oncology, Lancet Oncology, Nature Cancer and Cancer Discovery.

  • Daniel Kapp

    Daniel Kapp

    Professor of Radiation Oncology, Emeritus

    Current Research and Scholarly InterestsGynecologic malignancies; Rectal/and cancer; Breast Cancer; Hodgkin's disease; Hyperthermia; intraoperative radiation therapy; High dose rate radiation therapy; Predictive assays; Patterns of tumor spread; Health care finance.

  • Susan Knox

    Susan Knox

    Associate Professor of Radiation Oncology, Emerita

    Current Research and Scholarly InterestsOur interests include 1) study of the effect of radiation on regulatory cell subpopulations and co-stimulatory molecules, 2) use of radiation as an immune modulator for optimization of transplant regimens, 3) the role of radiation in tumor vaccine strategies, 4) study of new radiosensitizers and radioprotectors, and 5) discovery of new targeted therapies for the treatment of solid tumors.

  • Nataliya Kovalchuk

    Nataliya Kovalchuk

    Clinical Professor, Radiation Oncology - Radiation Physics

    BioEducation:
    2002 - B.S., Physics, Drohobych State University, Ukraine
    2004 - M.S., Physics, Minnesota State University, Mankato, MN
    2008 - Ph.D., Applied Physics, University of South Florida (H. Lee Moffitt Cancer Center and Research Institute), Tampa, FL
    2010 - Medical Physics Residency, Mayo Clinic, Rochester, MN

    Academic Appointments:
    2010 - 2015 - Instructor, Harvard Medical School, Massachusetts General Hospital/Boston Medical Center, Department of Radiation Oncology, Boston, MA
    2015 - 2019 - Clinical Assistant Professor, Stanford University, Department of Radiation Oncology, Stanford, CA
    2019 - 2024 - Clinical Associate Professor, Stanford University, Department of Radiation Oncology, Stanford, CA
    2019 - 2024 - Adjunct Associate Professor, MD Anderson Cancer Center/University of Texas, Houston, TX
    2024 - present - Clinical Professor, Stanford University, Department of Radiation Oncology, Stanford, CA
    2024 - present - Adjunct Professor, MD Anderson Cancer Center/University of Texas, Houston, TX